Víctor A. Cortés, et.al., Molecular mechanisms of hepatic steatosis and insulin resistance in the AGPAT2-deficient mouse model of congenital generalized lipodystrophy., Cell metabolism, 2009, 9

http://rdf.ncbi.nlm.nih.gov/pubmed/19187773

Víctor A. Cortés, et.al., Molecular mechanisms of hepatic steatosis and insulin resistance in the AGPAT2-deficient mouse model of congenital generalized lipodystrophy., Cell metabolism, 2009, 9

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Agpat2<tm1Garg>
  http://metadb.riken.jp/db/mgi_rdf/MGI:3838346

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• abnormal lipid homeostasis_Agpat2<tm1Garg>/Agpat2<tm1Garg>
  http://metadb.riken.jp/0002118I129S6SvEvTacAgpat2tm1GargAgpat2tm1GargAgpat2tm1Garg
• increased pancreatic beta cell mass_Agpat2<tm1Garg>/Agpat2<tm1Garg>
  http://metadb.riken.jp/0009113I129S6SvEvTacAgpat2tm1GargAgpat2tm1GargAgpat2tm1Garg
• hepatic steatosis_Agpat2<tm1Garg>/Agpat2<tm1Garg>
  http://metadb.riken.jp/0002628I129S6SvEvTacAgpat2tm1GargAgpat2tm1GargAgpat2tm1Garg
• decreased percent body fat/body weight_Agpat2<tm1Garg>/Agpat2<tm1Garg>
  http://metadb.riken.jp/0005459I129S6SvEvTacAgpat2tm1GargAgpat2tm1GargAgpat2tm1Garg
• abnormal fatty acid level_Agpat2<tm1Garg>/Agpat2<tm1Garg>
  http://metadb.riken.jp/0005280I129S6SvEvTacAgpat2tm1GargAgpat2tm1GargAgpat2tm1Garg
• insulin resistance_Agpat2<tm1Garg>/Agpat2<tm1Garg>
  http://metadb.riken.jp/0005331I129S6SvEvTacAgpat2tm1GargAgpat2tm1GargAgpat2tm1Garg
• increased liver weight_Agpat2<tm1Garg>/Agpat2<tm1Garg>
  http://metadb.riken.jp/0002981I129S6SvEvTacAgpat2tm1GargAgpat2tm1GargAgpat2tm1Garg
• hyperglycemia_Agpat2<tm1Garg>/Agpat2<tm1Garg>
  http://metadb.riken.jp/0001559I129S6SvEvTacAgpat2tm1GargAgpat2tm1GargAgpat2tm1Garg
• decreased survivor rate_Agpat2<tm1Garg>/Agpat2<tm1Garg>
  http://metadb.riken.jp/0008770I129S6SvEvTacAgpat2tm1GargAgpat2tm1GargAgpat2tm1Garg
• increased fluid intake_Agpat2<tm1Garg>/Agpat2<tm1Garg>
  http://metadb.riken.jp/0011941I129S6SvEvTacAgpat2tm1GargAgpat2tm1GargAgpat2tm1Garg
• increased spleen weight_Agpat2<tm1Garg>/Agpat2<tm1Garg>
  http://metadb.riken.jp/0004952I129S6SvEvTacAgpat2tm1GargAgpat2tm1GargAgpat2tm1Garg
• absent subcutaneous adipose tissue_Agpat2<tm1Garg>/Agpat2<tm1Garg>
  http://metadb.riken.jp/0008843I129S6SvEvTacAgpat2tm1GargAgpat2tm1GargAgpat2tm1Garg
• increased food intake_Agpat2<tm1Garg>/Agpat2<tm1Garg>
  http://metadb.riken.jp/0011939I129S6SvEvTacAgpat2tm1GargAgpat2tm1GargAgpat2tm1Garg
• increased liver triglyceride level_Agpat2<tm1Garg>/Agpat2<tm1Garg>
  http://metadb.riken.jp/0009355I129S6SvEvTacAgpat2tm1GargAgpat2tm1GargAgpat2tm1Garg
• decreased circulating leptin level_Agpat2<tm1Garg>/Agpat2<tm1Garg>
  http://metadb.riken.jp/0005668I129S6SvEvTacAgpat2tm1GargAgpat2tm1GargAgpat2tm1Garg
• decreased white adipose tissue amount_Agpat2<tm1Garg>/Agpat2<tm1Garg>
  http://metadb.riken.jp/0001783I129S6SvEvTacAgpat2tm1GargAgpat2tm1GargAgpat2tm1Garg
• abnormal glucose homeostasis_Agpat2<tm1Garg>/Agpat2<tm1Garg>
  http://metadb.riken.jp/0002078I129S6SvEvTacAgpat2tm1GargAgpat2tm1GargAgpat2tm1Garg
• abnormal small intestine morphology_Agpat2<tm1Garg>/Agpat2<tm1Garg>
  http://metadb.riken.jp/0000496I129S6SvEvTacAgpat2tm1GargAgpat2tm1GargAgpat2tm1Garg
• abnormal abdominal fat pad morphology_Agpat2<tm1Garg>/Agpat2<tm1Garg>
  http://metadb.riken.jp/0000010I129S6SvEvTacAgpat2tm1GargAgpat2tm1GargAgpat2tm1Garg
• increased oxygen consumption_Agpat2<tm1Garg>/Agpat2<tm1Garg>
  http://metadb.riken.jp/0005289I129S6SvEvTacAgpat2tm1GargAgpat2tm1GargAgpat2tm1Garg
• increased circulating insulin level_Agpat2<tm1Garg>/Agpat2<tm1Garg>
  http://metadb.riken.jp/0002079I129S6SvEvTacAgpat2tm1GargAgpat2tm1GargAgpat2tm1Garg
• abnormal phospholipid level_Agpat2<tm1Garg>/Agpat2<tm1Garg>
  http://metadb.riken.jp/0004777I129S6SvEvTacAgpat2tm1GargAgpat2tm1GargAgpat2tm1Garg
• abnormal gas homeostasis_Agpat2<tm1Garg>/Agpat2<tm1Garg>
  http://metadb.riken.jp/0003948I129S6SvEvTacAgpat2tm1GargAgpat2tm1GargAgpat2tm1Garg
• increased circulating triglyceride level_Agpat2<tm1Garg>/Agpat2<tm1Garg>
  http://metadb.riken.jp/0001552I129S6SvEvTacAgpat2tm1GargAgpat2tm1GargAgpat2tm1Garg
• increased carbon dioxide production_Agpat2<tm1Garg>/Agpat2<tm1Garg>
  http://metadb.riken.jp/0008963I129S6SvEvTacAgpat2tm1GargAgpat2tm1GargAgpat2tm1Garg
• postnatal lethality, incomplete penetrance_Agpat2<tm1Garg>/Agpat2<tm1Garg>
  http://metadb.riken.jp/0011086I129S6SvEvTacAgpat2tm1GargAgpat2tm1GargAgpat2tm1Garg
• decreased circulating free fatty acid level_Agpat2<tm1Garg>/Agpat2<tm1Garg>
  http://metadb.riken.jp/0002702I129S6SvEvTacAgpat2tm1GargAgpat2tm1GargAgpat2tm1Garg
• increased kidney weight_Agpat2<tm1Garg>/Agpat2<tm1Garg>
  http://metadb.riken.jp/0003917I129S6SvEvTacAgpat2tm1GargAgpat2tm1GargAgpat2tm1Garg
• decreased brown adipose tissue amount_Agpat2<tm1Garg>/Agpat2<tm1Garg>
  http://metadb.riken.jp/0001780I129S6SvEvTacAgpat2tm1GargAgpat2tm1GargAgpat2tm1Garg
• decreased total body fat amount_Agpat2<tm1Garg>/Agpat2<tm1Garg>
  http://metadb.riken.jp/0010025I129S6SvEvTacAgpat2tm1GargAgpat2tm1GargAgpat2tm1Garg
• decreased body temperature_Agpat2<tm1Garg>/Agpat2<tm1Garg>
  http://metadb.riken.jp/0005534I129S6SvEvTacAgpat2tm1GargAgpat2tm1GargAgpat2tm1Garg
• enlarged pancreatic islets_Agpat2<tm1Garg>/Agpat2<tm1Garg>
  http://metadb.riken.jp/0009171I129S6SvEvTacAgpat2tm1GargAgpat2tm1GargAgpat2tm1Garg
• hypoactivity_Agpat2<tm1Garg>/Agpat2<tm1Garg>
  http://metadb.riken.jp/0001402I129S6SvEvTacAgpat2tm1GargAgpat2tm1GargAgpat2tm1Garg
• decreased respiratory quotient_Agpat2<tm1Garg>/Agpat2<tm1Garg>
  http://metadb.riken.jp/0010379I129S6SvEvTacAgpat2tm1GargAgpat2tm1GargAgpat2tm1Garg

class

http://purl.org/net/cito/citesAsAuthority

• Agpat2<tm1Garg>
  http://metadb.riken.jp/db/mgi_rdf/MGI:3838346

トランスクリプトームデータ

http://rdf.ncbi.nlm.nih.gov/pubmed/

• CD23560
  http://metadb.riken.jp/db/BrainTx/TranscriptomeData/CD23560